Developing Drug Products in an Aging Society

Healthcare provision in an aging society: US perspective.- Healthcare provision in an aging society: European perspective.- Healthcare provision in an aging society: Japanese perspective.- Old, Very Old, and Frail.- Age and the process of aging.- Comprehensive Geriatric Assessment.- Patients' clinical characteristics, disease, experience, and perception.- Ethical considerations in performing clinical trials in and for older people.- Patient reported outcomes from a clinical to a therapeutic tool.- Pharmacokinetic and Pharmacodynamic Considerations in the Elderly Population.- The Expectation of a Treatment Model: A framework for adherence and Effectiveness.- Pharmacoepidemiology and pharmacovigilance for safety and efficacy in older people.- Defining patient centric drug product design and its impact on improving safety and effectiveness.- Dosing considerations in older adults.- Oral Drug Product Use in the Elderly Patient Population.- Drug product development for older adults - multiparticulate formulations.- Considerations for topical and transdermal drug delivery in older adults.- Injectable drug delivery for older patients.- Inhalation and Nasal Formulations.- Ophthalmic drug development and the elderly.- Developing drug administration devices for use by older patients.- Manufacturing Platforms for Patient-Centric Drug Products.- Novel Manufacturing Technologies for the Production of Patient-Centric Drug Products.- Prescribing to Older Adults.- Multimorbidity and Polypharmacy.- Vaccination in Older Adults.- Medication Reviews in Older Adults.- The Personalization of Drug therapy for Elderly patients.- Importance of Clinical Nutrition in Therapy to Older Adults.- Managing drug therapy of older patients in primary and secondary care.- Medication adherence and monitoring.- Medication compounding in the provision of drug therapy.- Geriatric Pharmacotherapy: Optimisation through integrated approach in the hospital setting.- European Medicines Agency (EMA): Regulatory perspectives on geriatric medicines.- Views on the Therapeutic Needs of Older Adults.- Future Perspectives in drug therapy of older people.- Opportunities in drug product development in an aging population.